Drilldown: Medicines
Appearance
Medicines > classes
:
[[:Category:Antihypertensives|Antihypertensive]]
or
the first approved
& fda max:
20 mg/d 
:
[[:Category:Antihypertensives|Antihypertensive]]
or
the first approved
& fda max:
20 mg/d 
Use the filters below to narrow your results.
Competitive antagonist at OX1R and OX2R. First-in-class DORA. Receptor dissociation slower than lemborexant or daridorexant. (1) ·
'"`UNIQ--vote-0000111B-QINU`"' Intraoperative floppy iris syndrome is a recognized class effect. Recently emerging evidence (observational) suggests possible Parkinson's disease risk reduction via PGK1 binding — investigational and not a clinical indication'"`UNIQ--ref-0000111C-QINU`"'. (1)
Showing below up to 2 results in range #1 to #2.

